Clorox Reports Q4 and FY24 Results, Provides FY25 Outlook

Go back to Clorox Reports Q4 and FY24 Results, Provides FY25 Outlook

Clorox (CLX) PT Lowered to $140 at Evercore ISI

August 2, 2024 5:54 AM EDT

Evercore ISI analyst Javier Escalante lowered the price target on Clorox (NYSE: CLX) to $140.00 (from $142.00) while maintaining a Underperform rating.

The analyst comments "Clorox beat this 4Q F24 on better gross margins, even as U.S. sales fell by 4% while consensus modeled flat. The controversy resides within Cloroxs most competitive household businesses,... More

Clorox (CLX) PT Raised to $148 at Jefferies

August 2, 2024 5:13 AM EDT

Jefferies analyst Kaumil Gajrawala raised the price target on Clorox (NYSE: CLX) to $148.00 (from $147.00) while maintaining a Hold rating.

The analyst comments "Clorox's F4Q results were mixed (top-line missed / EPS great on high margin expansion), while its F25 EPS outlook was above... More

Clorox (CLX) Tops Q4 EPS by 27c, Offers Guidance

August 1, 2024 4:13 PM EDT

Clorox (NYSE: CLX) reported Q4 EPS of $1.82, $0.27 better than the analyst estimate of $1.55. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.95 billion.

GUIDANCE:

Clorox sees FY2025 EPS of $6.55-$6.80, versus the consensus of $6.45.

Net sales are expected to be flat to down 2% compared to the prior year. Organic sales are expected to be up... More